These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surveys gain impressive stats. Titus K CAP Today; 1987 Sep; 1(9):1, 5-6. PubMed ID: 10325203 [No Abstract] [Full Text] [Related]
3. FDA's framework for regulatory oversight of LDTs. Pathak B; Terry SF Genet Test Mol Biomarkers; 2014 Dec; 18(12):785-6. PubMed ID: 25469801 [No Abstract] [Full Text] [Related]
4. How will the FDA impact the laboratory developed test? Davis J; Wentz J Clin Lab Sci; 2007; 20(3):130-1. PubMed ID: 17691668 [No Abstract] [Full Text] [Related]
5. The College of American Pathologists, 1946-1996. The surveys program. Wagner LR Arch Pathol Lab Med; 1997 Jun; 121(6):646-51. PubMed ID: 9199636 [No Abstract] [Full Text] [Related]
6. Society of Toxicologic Pathology position on histopathology data collection and audit trail: compliance with 21 CFR parts 58 and 11. Tuomari D; Elliott G; Kulwich B; Yarrington J; Fouillet X; Geoly F; Long P Toxicol Pathol; 2004; 32(1):122-3. PubMed ID: 14713556 [TBL] [Abstract][Full Text] [Related]
9. For labs, outcomes research may lead to catbird seat. Titus K CAP Today; 1997 Jun; 11(6):34-8, 40 passim. PubMed ID: 10174228 [No Abstract] [Full Text] [Related]
10. Regulating laboratory-developed tests: devil will be in details. McNeil C J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25838442 [No Abstract] [Full Text] [Related]
11. "Research use only" reagents: is there an imperative for increased FDA oversight? O'Leary TJ Clin Chem; 2011 Dec; 57(12):1681-3. PubMed ID: 21998341 [No Abstract] [Full Text] [Related]
12. The long and winding regulatory road for laboratory-developed tests. Weiss RL Am J Clin Pathol; 2012 Jul; 138(1):20-6. PubMed ID: 22706853 [TBL] [Abstract][Full Text] [Related]
13. US Food and Drug Administration regulatory oversight of laboratory-developed tests: Commentary on the draft guidance. Sidawy MK Cancer Cytopathol; 2015 Oct; 123(10):573-5. PubMed ID: 26042383 [No Abstract] [Full Text] [Related]
14. Modification of In Vitro Diagnostic Devices: Leveling the Playing Field. Rychert J; Delgado JC; Genzen JR Clin Chem; 2020 Jun; 66(6):760-762. PubMed ID: 32278318 [No Abstract] [Full Text] [Related]
15. FDA regulation of laboratory-developed diagnostic tests: protect the public, advance the science. Sharfstein J JAMA; 2015 Feb; 313(7):667-8. PubMed ID: 25560381 [No Abstract] [Full Text] [Related]
16. FDA announces plans to regulate LDTs. Cancer Discov; 2014 Nov; 4(11):1250. PubMed ID: 25367935 [No Abstract] [Full Text] [Related]